Do you want to read an article? Please log in or register.
Direct Oral Anticoagulant Adherence of Patients With Atrial Fibrillation Transitioned from Warfarin
Atrial FibrillationHeart, Artery and Coronary DiseasesTherapy and Intervention
Related content
Atrial Fibrillation
Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation
J Am Coll Cardiol.
Osmancik P, Herman D, Neuzil P, Hala P, Taborsky M, Kala P, Poloczek M, Stasek J, Haman L, Branny M, Chovancik J, Cervinka P, Holy J, Kovarnik T, Zemanek D, Havranek S, Vancura V, Opatrny J, Peichl P, Tousek P, Lekesova V, Jarkovsky J, Novackova M, Benesova K, Widimsky P, Reddy VY, PRAGUE-17 Trial Investigators.
doi: 10.1016/j.jacc.2020.04.067.
Atrial Fibrillation
Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant
JAMA Intern Med.
Douketis JD, Spyropoulos AC, Duncan J, Carrier M, Le Gal G, Tafur AJ, Vanassche T, Verhamme P, Shivakumar S, Gross PL, Lee AYY, Yeo E, Solymoss S, Kassis J, Le Templier G, Kowalski S, Blostein M, Shah V, MacKay E, Wu C, Clark NP, Bates SM, Spencer FA, Arnaoutoglou E, Coppens M, Arnold DM, Caprini JA, Li N, Moffat KA, Syed S, Schulman S
doi: 10.1001/jamainternmed.2019.2431.
Atrial Fibrillation
Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
BMJ.
Nielsen PB, Skjøth F, Søgaard M, Kjældgaard JN, Lip GY, Larsen TB
doi: 10.1136/bmj.j510.
Atrial Fibrillation
Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)
Am Heart J.
Jackson LR 2nd, Kim S, Blanco R, Thomas L, Ansell J, Fonarow GC, Gersh BJ, Go AS, Kowey PR, Mahaffey KW, Hylek EM, Peterson ED, Piccini JP, Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II.
doi: 10.1016/j.ahj.2020.04.016.
Atrial FibrillationThrombosis and StrokeTherapy and Intervention
Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation
J Am Heart Assoc.
Martinez BK, Sood NA, Bunz TJ, Coleman CI
doi: 10.1161/JAHA.118.008643.
COMMENTED
Atrial Fibrillation
Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants
★ 2
Recommended and commented by
Prof. Dr Sacha P. Salzberg, Faculty Member
J Am Coll Cardiol
Camm AJ, Cools F, Virdone S, Bassand JP, Fitzmaurice DA, Arthur Fox KA, Goldhaber SZ, Goto S, Haas S, Mantovani LG, Kayani G, Grierson Turpie AG, Antoon Verheugt FW, Kakkar AK, GARFIELD-AF Investigators.
doi: 10.1016/j.jacc.2020.07.045
Atrial FibrillationTherapy and Intervention
Less dementia with oral anticoagulation in atrial fibrillation
Eur Heart J.
Friberg L, Rosenqvist M
doi: 10.1093/
Atrial FibrillationThrombosis and Stroke
Laboratory Monitoring of Non-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation: A Review
JAMA Cardiol.
Eikelboom JW, Quinlan DJ, Hirsh J, Connolly SJ, Weitz JI
doi: 10.1001/jamacardio.
Atrial Fibrillation
Direct Current Cardioversion of Atrial Fibrillation in Patients With Left Atrial Appendage Occlusion Devices
J Am Coll Cardiol.
Sharma SP, Turagam MK, Gopinathannair R, Reddy V, Kar S, Mohanty S, Cheng J, Holmes DR Jr, Sondergaard L, Natale A, Lakkireddy D
doi: 10.1016/j.jacc.2019.08.1045.Visit the original publication at ncbi.nlm.nih.gov